Meriwether Wealth & Planning’s Revolution Medicines RVMD Stock Holding History

Meriwether Wealth & Planning’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.26K	Buy	+11	New	+$2.18K	﹤0.01%	623

Other funds holding RVMD

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Loftus Peak Sydney, Australia $781M AUM

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Meriwether Wealth & Planning's RVMD Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Revolution Medicines (RVMD) in Q3 2026: 11 shares worth $2.26K. The stake represents ﹤0.01% of the portfolio and ranks #623 among its holdings.

212 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

Meriwether Wealth & Planning held 11 shares of Revolution Medicines worth $2.26K as of Q3 2026.
Revolution Medicines was a new Meriwether Wealth & Planning position in Q3 2026.
Revolution Medicines made up ﹤0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #623 holding.
212 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.